Post Market Clinical Follow up of ResMed Mask Systems

Abroad (travel likely)Recruiting

Conditions

Obstructive Sleep Apnea

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Medical Affairs ResMed, Sydney, New South Wales, Australia
Contact: Study coordinator (Jeff Armitstead, PhD) · 61488840000

Study leads

Jeff Armistead, PhD
Principal Investigator
ResMed

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Atomoxetine and DAW2022 on OSA Severity

Obstructive Sleep Apnea

Abroad (travel likely)RecruitingPHASE1, PHASE2

Boston, United States

Maridebart Cafraglutide Versus Placebo in Adult Participants With Obstructive Sleep Apnea Not on Positive Airway Pressure (PAP) Therapy

Obstructive Sleep Apnea

Abroad (travel likely)RecruitingPHASE3

Northridge, United States · Rolling Hills Estates, United States

Early Dental Risk Screening for Pediatric Sleep-Disordered Breathing

Early Risk Screening for Sleep Disordered Breathing in a Dental Setting · Sleep Disordered Breathing (SDB) · Obstructive Sleep Apnea (OSA)

Abroad (travel likely)Recruiting

Chapel Hill, United States

Neurocognitive and Health Impact of Sleep Apnea in Elderly Veterans With Comorbid COPD

Obstructive Sleep Apnea · OSA COPD Overlap Syndrome

Abroad (travel likely)Recruiting

Detroit, United States